{Reference Type}: Case Reports
{Title}: Rhabdomyolysis in the Setting of Concomitant Use of Tafamidis, Atorvastatin, and Amiodarone.
{Author}: Laird J;Falk RH;Coyle M;Cuddy SAM;
{Journal}: JACC Case Rep
{Volume}: 2
{Issue}: 15
{Year}: Dec 2020
暂无{DOI}: 10.1016/j.jaccas.2020.09.037
{Abstract}: An 85-year-old women with transthyretin cardiac amyloidosis presented with generalized weakness, elevated liver function test levels, and creatinine kinase consistent with rhabdomyolysis 1 week after starting tafamidis. She was already taking atorvastatin and amiodarone, raising the possibility of a drug-drug interaction inhibiting the breakdown and excretion of atorvastatin, causing drug-induced rhabdomyolysis. (Level of Difficulty: Intermediate.).